- Home
- DHY vs KOD Comparison
DHY vs KOD Comparison
Compare DHY & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHY
- KOD
- Stock Information
- Founded
- DHY 1998
- KOD 2009
- Country
- DHY United States
- KOD United States
- Employees
- DHY N/A
- KOD N/A
- Industry
- DHY Finance/Investors Services
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DHY Finance
- KOD Health Care
- Exchange
- DHY Nasdaq
- KOD Nasdaq
- Market Cap
- DHY 211.3M
- KOD 188.9M
- IPO Year
- DHY N/A
- KOD 2018
- Fundamental
- Price
- DHY $2.13
- KOD $3.95
- Analyst Decision
- DHY
- KOD Hold
- Analyst Count
- DHY 0
- KOD 3
- Target Price
- DHY N/A
- KOD $9.00
- AVG Volume (30 Days)
- DHY 569.1K
- KOD 293.9K
- Earning Date
- DHY 01-01-0001
- KOD 08-13-2025
- Dividend Yield
- DHY 9.10%
- KOD N/A
- EPS Growth
- DHY N/A
- KOD N/A
- EPS
- DHY N/A
- KOD N/A
- Revenue
- DHY N/A
- KOD N/A
- Revenue This Year
- DHY N/A
- KOD N/A
- Revenue Next Year
- DHY N/A
- KOD N/A
- P/E Ratio
- DHY N/A
- KOD N/A
- Revenue Growth
- DHY N/A
- KOD N/A
- 52 Week Low
- DHY $1.77
- KOD $1.92
- 52 Week High
- DHY $2.08
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- DHY 74.31
- KOD 53.45
- Support Level
- DHY $2.12
- KOD $3.60
- Resistance Level
- DHY $2.00
- KOD $3.97
- Average True Range (ATR)
- DHY 0.02
- KOD 0.24
- MACD
- DHY 0.00
- KOD 0.01
- Stochastic Oscillator
- DHY 88.89
- KOD 63.43
About DHY Credit Suisse High Yield Bond Fund
Credit Suisse High Yield Bond Fund is a non-diversified, closed-end management investment company to seeks high current income and capital appreciation as a secondary objective.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.